NMVA Stock Overview
Captor Capital Corp. engages in the retail sale of cannabis products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Captor Capital Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.04 |
| 52 Week High | CA$0.11 |
| 52 Week Low | CA$0.0005 |
| Beta | -0.012 |
| 1 Month Change | 3,900.00% |
| 3 Month Change | 63.27% |
| 1 Year Change | n/a |
| 3 Year Change | -96.55% |
| 5 Year Change | -95.82% |
| Change since IPO | -98.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| NMVA | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | -2.0% |
| 1Y | n/a | -31.9% | -0.3% |
Return vs Industry: Insufficient data to determine how NMVA performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how NMVA performed against the German Market.
Price Volatility
| NMVA volatility | |
|---|---|
| NMVA Average Weekly Movement | 819.7% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NMVA's share price has been volatile over the past 3 months.
Volatility Over Time: NMVA's weekly volatility has increased from 485% to 820% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 78 | John Zorbas | captorcapital.com |
Captor Capital Corp. engages in the retail sale of cannabis products in the United States. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. on June 2, 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.
Captor Capital Corp. Fundamentals Summary
| NMVA fundamental statistics | |
|---|---|
| Market cap | €1.61m |
| Earnings (TTM) | -€9.48m |
| Revenue (TTM) | €25.16m |
0.1x
P/S Ratio-0.2x
P/E RatioIs NMVA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NMVA income statement (TTM) | |
|---|---|
| Revenue | CA$36.72m |
| Cost of Revenue | CA$20.06m |
| Gross Profit | CA$16.66m |
| Other Expenses | CA$30.50m |
| Earnings | -CA$13.84m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 45.37% |
| Net Profit Margin | -37.69% |
| Debt/Equity Ratio | 0.5% |
How did NMVA perform over the long term?
See historical performance and comparison